After 5 weeks of treatment with once-daily subcutaneous administration of liraglutide 1.8 mg and 3.0 mg, estimated reductions in body weight were 2.1 kg and 2.5 kg, respectively, vs
Its important to note that GLP-1 injections are not recommended for individuals with certain thyroid conditions, including a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, as well as for pregnant or breastfeeding women
Bariatric surgery, while still requiring an upfront investment and dietary and lifestyle changes, is covered by most major insurance plans and Medicare for qualifying patients and it's a one-time procedure, not a recurring monthly expense
It increases the risk for multiple metabolic complications including type 2 diabetes (T2D), metabolic-dysfunction associated steatotic liver disease (MASLD, previously known as non-alcoholic fatty liver disease), cardiovascular disease as well as many mechanical complications such as osteoarthritis and obstructive sleep apnoea (OSA) [3]
Singh S, Wright EE Jr, Kwan AY, et al